Ann: Half Year Results Investor Webinar, page-17

It's baffling to see how bemused they appear that people expect them to see things through instead of generate a list of partially undertaken and hypothetical thought bubbles. At least there is a black and white list of what they should accomplish this year and they can be properly held to account and hopefully removed if they fail to deliver. The two pillars for me are growing revenue from EPP and progress with the Vitiligo trial. The first looks to be teetering and the latter is shrouded by another of their bizarre cognitive impairments that prevent them releasing a detailed update. Hopefully this happens soon to restore some faith in their beleaguered long-term holders